Pox­el pass­es 3rd straight Phase III di­a­betes tri­al in Japan, but what's go­ing on with US/EU part­ner Roivant?

Pox­el and its new di­a­betes tablet are head­ing to reg­u­la­tors. Well, in Japan at least.

The French phar­ma and its Japan­ese part­ner Sum­it­o­mo Dainip­pon an­nounced …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER